Long Non-Coding RNA Signatures Associated with Ferroptosis Predict Prognosis in Colorectal Cancer
Currently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a vital role in the pathology and progression of colorectal tumors. A total of 627 patients (51 normal and 644 tumor samples) from The Cancer Genome Atlas (...
Saved in:
| Published in | International journal of general medicine Vol. 15; pp. 33 - 43 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New Zealand
Dove Medical Press Limited
01.01.2022
Taylor & Francis Ltd Dove Dove Medical Press |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1178-7074 1178-7074 |
| DOI | 10.2147/IJGM.S331378 |
Cover
| Abstract | Currently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a vital role in the pathology and progression of colorectal tumors.
A total of 627 patients (51 normal and 644 tumor samples) from The Cancer Genome Atlas (TCGA)-COAD and TCGA-READ were included in the study. Lasso and Cox's regression was employed to analyze the characteristic lncRNAs in colorectal cancer samples, and a distinctive prognostic model of ferroptosis-related lncRNAs was established. By analyzing the divergence between the high and low-risk groups of ferroptosis-related lncRNAs, 15 characteristic lncRNAs related to the prognosis of colorectal cancer were evaluated. Kaplan-Meier analysis, operation characteristic curve (ROC), nomogram, and gene set enrichment analyses (GSEA) further confirmed the validity of the characteristic prognostic model with ferroptosis-related lncRNAs.
Kaplan-Meier analysis confirmed a high-risk group of ferroptosis-related lncRNA interrelated with a poor prognosis in colorectal cancer. AUC estimates of 1 -, 3 -, and 5-year survival rates for ferroptosis-related lncRNA characteristic models were 0.745, 0.767 and 0.789. GSEA analysis showed that immune and malignancy-related pathways were active in the high-risk score group. In addition, differential analyses of immune function, including Checkpoint, cytolytic, HLA, and T cell co-inhibition, differed significantly betwixt low - and high-risk groups.
, and other immune checkpoints had different expressions betwixt the high- and low-risk group.
Fifteen kinds of lncRNAs with different expressions (AP003555.1, AC099850.3, AL031985.3, LINC01857, STPG3-AS1, AL137782.1, AC124067.4, AC012313.5, AC083900.1, AC010973.2, ALMS1-IT1, AC013652.1, AC133540.1, AP006621.2, AC018653.3) were closely associated with poor prognosis of colorectal cancer. These indicators were significantly correlated with the overall survival (OS) rate and could be used as prognostic evaluation criteria. |
|---|---|
| AbstractList | Background: Currently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a vital role in the pathology and progression of colorectal tumors. Methods: A total of 627 patients (51 normal and 644 tumor samples) from The Cancer Genome Atlas (TCGA)-COAD and TCGA-READ were included in the study. Lasso and Cox's regression was employed to analyze the characteristic lncRNAs in colorectal cancer samples, and a distinctive prognostic model of ferroptosis-related lncRNAs was established. By analyzing the divergence between the high and low-risk groups of ferroptosis-related lncRNAs, 15 characteristic lncRNAs related to the prognosis of colorectal cancer were evaluated. Kaplan-Meier analysis, operation characteristic curve (ROC), nomogram, and gene set enrichment analyses (GSEA) further confirmed the validity of the characteristic prognostic model with ferroptosis-related lncRNAs. Results: Kaplan-Meier analysis confirmed a high-risk group of ferroptosis-related lncRNA interrelated with a poor prognosis in colorectal cancer. AUC estimates of 1 -, 3 -, and 5-year survival rates for ferroptosis-related lncRNA characteristic models were 0.745, 0.767 and 0.789. GSEA analysis showed that immune and malignancy-related pathways were active in the high-risk score group. In addition, differential analyses of immune function, including Checkpoint, cytolytic, HLA, and T cell co-inhibition, differed significantly betwixt low - and high-risk groups.CD160, TNFRSF18, CD27, PDCD1, CD200R1, ADORA2A, TNFRSF14, LAIR1, CD244, CD40, TNFRSF4, CD70, TNFSF14, TNFRSF25, CD276, HHLA2, VTCN1, LAG3, TNFSF18, and other immune checkpoints had different expressions betwixt the high- and low-risk group. Conclusion: Fifteen kinds of lncRNAs with different expressions (AP003555.1, AC099850.3, AL031985.3, LINC01857, STPG3-AS1, AL137782.1, AC124067.4, AC012313.5, AC083900.1, AC010973.2, ALMS1-IT1, AC013652.1, AC133540.1, AP006621.2, AC018653.3) were closely associated with poor prognosis of colorectal cancer. These indicators were significantly correlated with the overall survival (OS) rate and could be used as prognostic evaluation criteria. Keywords: colorectal cancer, ferroptosis, lncRNAs, immune infiltration, TCGA Currently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a vital role in the pathology and progression of colorectal tumors. A total of 627 patients (51 normal and 644 tumor samples) from The Cancer Genome Atlas (TCGA)-COAD and TCGA-READ were included in the study. Lasso and Cox's regression was employed to analyze the characteristic lncRNAs in colorectal cancer samples, and a distinctive prognostic model of ferroptosis-related lncRNAs was established. By analyzing the divergence between the high and low-risk groups of ferroptosis-related lncRNAs, 15 characteristic lncRNAs related to the prognosis of colorectal cancer were evaluated. Kaplan-Meier analysis, operation characteristic curve (ROC), nomogram, and gene set enrichment analyses (GSEA) further confirmed the validity of the characteristic prognostic model with ferroptosis-related lncRNAs. Kaplan-Meier analysis confirmed a high-risk group of ferroptosis-related lncRNA interrelated with a poor prognosis in colorectal cancer. AUC estimates of 1 -, 3 -, and 5-year survival rates for ferroptosis-related lncRNA characteristic models were 0.745, 0.767 and 0.789. GSEA analysis showed that immune and malignancy-related pathways were active in the high-risk score group. In addition, differential analyses of immune function, including Checkpoint, cytolytic, HLA, and T cell co-inhibition, differed significantly betwixt low - and high-risk groups. , and other immune checkpoints had different expressions betwixt the high- and low-risk group. Fifteen kinds of lncRNAs with different expressions (AP003555.1, AC099850.3, AL031985.3, LINC01857, STPG3-AS1, AL137782.1, AC124067.4, AC012313.5, AC083900.1, AC010973.2, ALMS1-IT1, AC013652.1, AC133540.1, AP006621.2, AC018653.3) were closely associated with poor prognosis of colorectal cancer. These indicators were significantly correlated with the overall survival (OS) rate and could be used as prognostic evaluation criteria. Currently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a vital role in the pathology and progression of colorectal tumors.BACKGROUNDCurrently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a vital role in the pathology and progression of colorectal tumors.A total of 627 patients (51 normal and 644 tumor samples) from The Cancer Genome Atlas (TCGA)-COAD and TCGA-READ were included in the study. Lasso and Cox's regression was employed to analyze the characteristic lncRNAs in colorectal cancer samples, and a distinctive prognostic model of ferroptosis-related lncRNAs was established. By analyzing the divergence between the high and low-risk groups of ferroptosis-related lncRNAs, 15 characteristic lncRNAs related to the prognosis of colorectal cancer were evaluated. Kaplan-Meier analysis, operation characteristic curve (ROC), nomogram, and gene set enrichment analyses (GSEA) further confirmed the validity of the characteristic prognostic model with ferroptosis-related lncRNAs.METHODSA total of 627 patients (51 normal and 644 tumor samples) from The Cancer Genome Atlas (TCGA)-COAD and TCGA-READ were included in the study. Lasso and Cox's regression was employed to analyze the characteristic lncRNAs in colorectal cancer samples, and a distinctive prognostic model of ferroptosis-related lncRNAs was established. By analyzing the divergence between the high and low-risk groups of ferroptosis-related lncRNAs, 15 characteristic lncRNAs related to the prognosis of colorectal cancer were evaluated. Kaplan-Meier analysis, operation characteristic curve (ROC), nomogram, and gene set enrichment analyses (GSEA) further confirmed the validity of the characteristic prognostic model with ferroptosis-related lncRNAs.Kaplan-Meier analysis confirmed a high-risk group of ferroptosis-related lncRNA interrelated with a poor prognosis in colorectal cancer. AUC estimates of 1 -, 3 -, and 5-year survival rates for ferroptosis-related lncRNA characteristic models were 0.745, 0.767 and 0.789. GSEA analysis showed that immune and malignancy-related pathways were active in the high-risk score group. In addition, differential analyses of immune function, including Checkpoint, cytolytic, HLA, and T cell co-inhibition, differed significantly betwixt low - and high-risk groups.CD160, TNFRSF18, CD27, PDCD1, CD200R1, ADORA2A, TNFRSF14, LAIR1, CD244, CD40, TNFRSF4, CD70, TNFSF14, TNFRSF25, CD276, HHLA2, VTCN1, LAG3, TNFSF18, and other immune checkpoints had different expressions betwixt the high- and low-risk group.RESULTSKaplan-Meier analysis confirmed a high-risk group of ferroptosis-related lncRNA interrelated with a poor prognosis in colorectal cancer. AUC estimates of 1 -, 3 -, and 5-year survival rates for ferroptosis-related lncRNA characteristic models were 0.745, 0.767 and 0.789. GSEA analysis showed that immune and malignancy-related pathways were active in the high-risk score group. In addition, differential analyses of immune function, including Checkpoint, cytolytic, HLA, and T cell co-inhibition, differed significantly betwixt low - and high-risk groups.CD160, TNFRSF18, CD27, PDCD1, CD200R1, ADORA2A, TNFRSF14, LAIR1, CD244, CD40, TNFRSF4, CD70, TNFSF14, TNFRSF25, CD276, HHLA2, VTCN1, LAG3, TNFSF18, and other immune checkpoints had different expressions betwixt the high- and low-risk group.Fifteen kinds of lncRNAs with different expressions (AP003555.1, AC099850.3, AL031985.3, LINC01857, STPG3-AS1, AL137782.1, AC124067.4, AC012313.5, AC083900.1, AC010973.2, ALMS1-IT1, AC013652.1, AC133540.1, AP006621.2, AC018653.3) were closely associated with poor prognosis of colorectal cancer. These indicators were significantly correlated with the overall survival (OS) rate and could be used as prognostic evaluation criteria.CONCLUSIONFifteen kinds of lncRNAs with different expressions (AP003555.1, AC099850.3, AL031985.3, LINC01857, STPG3-AS1, AL137782.1, AC124067.4, AC012313.5, AC083900.1, AC010973.2, ALMS1-IT1, AC013652.1, AC133540.1, AP006621.2, AC018653.3) were closely associated with poor prognosis of colorectal cancer. These indicators were significantly correlated with the overall survival (OS) rate and could be used as prognostic evaluation criteria. Background: Currently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a vital role in the pathology and progression of colorectal tumors. Methods: A total of 627 patients (51 normal and 644 tumor samples) from The Cancer Genome Atlas (TCGA)-COAD and TCGA-READ were included in the study. Lasso and Cox’s regression was employed to analyze the characteristic lncRNAs in colorectal cancer samples, and a distinctive prognostic model of ferroptosis-related lncRNAs was established. By analyzing the divergence between the high and low-risk groups of ferroptosis-related lncRNAs, 15 characteristic lncRNAs related to the prognosis of colorectal cancer were evaluated. Kaplan–Meier analysis, operation characteristic curve (ROC), nomogram, and gene set enrichment analyses (GSEA) further confirmed the validity of the characteristic prognostic model with ferroptosis-related lncRNAs. Results: Kaplan–Meier analysis confirmed a high-risk group of ferroptosis-related lncRNA interrelated with a poor prognosis in colorectal cancer. AUC estimates of 1 -, 3 -, and 5-year survival rates for ferroptosis-related lncRNA characteristic models were 0.745, 0.767 and 0.789. GSEA analysis showed that immune and malignancy-related pathways were active in the high-risk score group. In addition, differential analyses of immune function, including Checkpoint, cytolytic, HLA, and T cell co-inhibition, differed significantly betwixt low - and high-risk groups.CD160, TNFRSF18, CD27, PDCD1, CD200R1, ADORA2A, TNFRSF14, LAIR1, CD244, CD40, TNFRSF4, CD70, TNFSF14, TNFRSF25, CD276, HHLA2, VTCN1, LAG3, TNFSF18, and other immune checkpoints had different expressions betwixt the high- and low-risk group. Conclusion: Fifteen kinds of lncRNAs with different expressions (AP003555.1, AC099850.3, AL031985.3, LINC01857, STPG3-AS1, AL137782.1, AC124067.4, AC012313.5, AC083900.1, AC010973.2, ALMS1-IT1, AC013652.1, AC133540.1, AP006621.2, AC018653.3) were closely associated with poor prognosis of colorectal cancer. These indicators were significantly correlated with the overall survival (OS) rate and could be used as prognostic evaluation criteria. Na Li,1 Jiangli Shen,1 Ximin Qiao,2 Yuan Gao,3 Hong-Bo Su,4 Shuai Zhang5 1Department of Anorectal Surgery, Xianyang Central Hospital, Xianyang, Shaanxi Province, People’s Republic of China; 2Dean’s Office, Xianyang Central Hospital, Xianyang, Shaanxi Province, People’s Republic of China; 3Surgery Department, Xianyang Central Hospital, Xianyang, Shaanxi Province, People’s Republic of China; 4The Second Ward of the Anorectal Hospital, Xi’an Hospital of TCM, Xi’an, Shaanxi Province, People’s Republic of China; 5Journal Editorial Board, Hebei University of Chinese Medicine, Hebei, People’s Republic of ChinaCorrespondence: Hong-Bo Su; Shuai Zhang Email mihxv9@163.com; mgqcr0@163.comBackground: Currently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a vital role in the pathology and progression of colorectal tumors.Methods: A total of 627 patients (51 normal and 644 tumor samples) from The Cancer Genome Atlas (TCGA)-COAD and TCGA-READ were included in the study. Lasso and Cox’s regression was employed to analyze the characteristic lncRNAs in colorectal cancer samples, and a distinctive prognostic model of ferroptosis-related lncRNAs was established. By analyzing the divergence between the high and low-risk groups of ferroptosis-related lncRNAs, 15 characteristic lncRNAs related to the prognosis of colorectal cancer were evaluated. Kaplan–Meier analysis, operation characteristic curve (ROC), nomogram, and gene set enrichment analyses (GSEA) further confirmed the validity of the characteristic prognostic model with ferroptosis-related lncRNAs.Results: Kaplan–Meier analysis confirmed a high-risk group of ferroptosis-related lncRNA interrelated with a poor prognosis in colorectal cancer. AUC estimates of 1 -, 3 -, and 5-year survival rates for ferroptosis-related lncRNA characteristic models were 0.745, 0.767 and 0.789. GSEA analysis showed that immune and malignancy-related pathways were active in the high-risk score group. In addition, differential analyses of immune function, including Checkpoint, cytolytic, HLA, and T cell co-inhibition, differed significantly betwixt low - and high-risk groups.CD160, TNFRSF18, CD27, PDCD1, CD200R1, ADORA2A, TNFRSF14, LAIR1, CD244, CD40, TNFRSF4, CD70, TNFSF14, TNFRSF25, CD276, HHLA2, VTCN1, LAG3, TNFSF18, and other immune checkpoints had different expressions betwixt the high- and low-risk group.Conclusion: Fifteen kinds of lncRNAs with different expressions (AP003555.1, AC099850.3, AL031985.3, LINC01857, STPG3-AS1, AL137782.1, AC124067.4, AC012313.5, AC083900.1, AC010973.2, ALMS1-IT1, AC013652.1, AC133540.1, AP006621.2, AC018653.3) were closely associated with poor prognosis of colorectal cancer. These indicators were significantly correlated with the overall survival (OS) rate and could be used as prognostic evaluation criteria.Keywords: colorectal cancer, ferroptosis, lncRNAs, immune infiltration, TCGA |
| Audience | Academic |
| Author | Gao, Yuan Li, Na Zhang, Shuai Shen, Jiangli Su, Hong-Bo Qiao, Ximin |
| Author_xml | – sequence: 1 givenname: Na orcidid: 0000-0001-6821-2518 surname: Li fullname: Li, Na – sequence: 2 givenname: Jiangli orcidid: 0000-0001-8380-3287 surname: Shen fullname: Shen, Jiangli – sequence: 3 givenname: Ximin surname: Qiao fullname: Qiao, Ximin – sequence: 4 givenname: Yuan orcidid: 0000-0001-8610-7981 surname: Gao fullname: Gao, Yuan – sequence: 5 givenname: Hong-Bo orcidid: 0000-0002-6850-0656 surname: Su fullname: Su, Hong-Bo – sequence: 6 givenname: Shuai orcidid: 0000-0001-8323-9831 surname: Zhang fullname: Zhang, Shuai |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35018112$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkk1vEzEQhleoiH7AjTNaCQlxYIM_1mvvpVIU0RIUCiJwthzbu3Hk2MH2UvXf4zQlSkrlw1jjZ94Zv5rz4sR5p4viNQQjBGv6cfrl-utojjHElD0rziCkrKKA1icH99PiPMYVAE3TQPyiOMUEQAYhOivEzLu-vPGumnhl8vXHzbicm96JNAQdy3GMXhqRtCpvTVqWVzoEv0k-mlh-D1oZmXL0vbvPGFdOvPVByyRsORFO6vCyeN4JG_Wrh3hR_Lr69HPyuZp9u55OxrNKEtqkqtWaEIyoIAILKNtay1ZQoAgiqkGY1AB1QLEOgkULuqYWqK411LVSgAElKL4opjtd5cWKb4JZi3DHvTD8PuFDz0VIRlrNCZUdzRKUZW8owi1juOkYWmhRSwh11qp2WoPbiLtbYe1eEAK-tZ2bVb_mcWd75i93_GZYrLWS2qUg7NEQxy_OLHnv_3BGa9QAnAXePwgE_3vQMfG1iVJbK5z2Q-SogS2ChDCU0beP0JUfgsvWZgoBACAlB1Qv8oeN63zuK7eifNy0NWgoZk2mRk9Q-Si9NjLvWWdy_qjg3UHBUgubltHbIRnv4jH45tCRvRX_Ni8DH3aADD7GoLv_HN4uNp_vHUaPcGmS2LbNExv7dNFf5F723w |
| CitedBy_id | crossref_primary_10_2139_ssrn_4128887 crossref_primary_10_3892_ol_2024_14417 crossref_primary_10_3389_fgene_2022_942785 crossref_primary_10_3389_fonc_2022_961213 crossref_primary_10_1186_s12859_023_05203_5 crossref_primary_10_3390_molecules28010243 crossref_primary_10_5306_wjco_v15_i1_89 crossref_primary_10_1016_j_ajps_2022_09_002 crossref_primary_10_3389_fonc_2022_920023 crossref_primary_10_3389_fphar_2022_1043283 crossref_primary_10_3389_fgene_2022_952836 crossref_primary_10_3390_cells13100794 crossref_primary_10_1186_s12885_022_09805_9 crossref_primary_10_1186_s12935_023_03065_8 crossref_primary_10_1097_MD_0000000000031314 crossref_primary_10_3390_biology12081101 crossref_primary_10_1186_s12967_024_05576_y crossref_primary_10_1016_j_mrfmmm_2023_111828 crossref_primary_10_1097_MD_0000000000033114 crossref_primary_10_1016_j_mrrev_2023_108465 crossref_primary_10_1177_03000605241274563 crossref_primary_10_1111_jcmm_70103 crossref_primary_10_1186_s12935_024_03374_6 crossref_primary_10_1186_s12876_022_02200_5 crossref_primary_10_1007_s10549_024_07428_1 crossref_primary_10_3389_fimmu_2025_1514238 crossref_primary_10_3390_life13071557 crossref_primary_10_1038_s41598_023_32757_4 |
| Cites_doi | 10.1186/s12935-021-02027-2 10.3892/etm.2018.6775 10.3389/fimmu.2019.02368 10.1158/1078-0432.CCR-14-1495 10.1016/j.molcel.2016.03.021 10.1016/j.ejcb.2018.04.005 10.1093/database/baaa021 10.1016/j.cell.2018.01.011 10.1016/j.gde.2017.07.009 10.1038/s41417-020-00267-4 10.1016/S0140-6736(19)32319-0 10.1007/978-1-4939-7493-1_12 10.1080/14737140.2018.1480942 10.26355/eurrev_202004_20827 10.17305/bjbms.2020.5617 10.3389/fonc.2020.00846 10.1016/j.yexmp.2021.104642 10.3389/fonc.2021.614778 10.1038/ncomms3612 10.1002/jcp.28090 10.1158/0008-5472.CAN-17-0307 10.1002/1878-0261.12851 10.1016/j.eururo.2018.08.038 10.18632/oncotarget.13263 10.1016/j.jmoldx.2019.08.006 |
| ContentType | Journal Article |
| Copyright | 2022 Li et al. COPYRIGHT 2022 Dove Medical Press Limited 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 Li et al. 2022 Li et al. |
| Copyright_xml | – notice: 2022 Li et al. – notice: COPYRIGHT 2022 Dove Medical Press Limited – notice: 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 Li et al. 2022 Li et al. |
| DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.2147/IJGM.S331378 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Research Library (ProQuest) Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 4 dbid: BENPR name: ProQuest Databases url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Li et al |
| EISSN | 1178-7074 |
| EndPage | 43 |
| ExternalDocumentID | oai_doaj_org_article_57cf764a7807472398836f82bea4c11e 10.2147/ijgm.s331378 PMC8742603 A694067386 35018112 10_2147_IJGM_S331378 |
| Genre | Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- 0YH 29J 2WC 53G 5GY 5VS 7X7 8FI 8FJ 8G5 AAYXX ABUWG ACGFO ADBBV ADRAZ AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI C1A CCPQU CITATION DIK DWQXO E3Z EBD F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HMCUK HYE IAO IHR IHW IPNFZ ITC KQ8 M2O M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PUEGO RIG RNS RPM TDBHL TR2 UKHRP VDV ALIPV NPM AQTUD 3V. 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c576t-9ee55327a5a3a1c94ec9a70d525d6235402f0d8f10b90f64a244e1e4dd080da73 |
| IEDL.DBID | M48 |
| ISSN | 1178-7074 |
| IngestDate | Fri Oct 03 12:50:48 EDT 2025 Sun Oct 26 04:14:24 EDT 2025 Tue Sep 30 16:36:31 EDT 2025 Thu Oct 02 07:18:55 EDT 2025 Tue Oct 07 06:58:46 EDT 2025 Mon Oct 20 22:20:03 EDT 2025 Mon Oct 20 16:46:49 EDT 2025 Thu May 22 21:22:40 EDT 2025 Thu Jan 02 22:54:07 EST 2025 Wed Oct 01 01:50:46 EDT 2025 Thu Apr 24 22:58:54 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | lncRNAs colorectal cancer ferroptosis immune infiltration TCGA |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc/3.0 2022 Li et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). cc-by-nc |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c576t-9ee55327a5a3a1c94ec9a70d525d6235402f0d8f10b90f64a244e1e4dd080da73 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-8380-3287 0000-0001-8323-9831 0000-0001-8610-7981 0000-0001-6821-2518 0000-0002-6850-0656 |
| OpenAccessLink | https://www.proquest.com/docview/2620001752?pq-origsite=%requestingapplication%&accountid=15518 |
| PMID | 35018112 |
| PQID | 2620001752 |
| PQPubID | 3933151 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_57cf764a7807472398836f82bea4c11e unpaywall_primary_10_2147_ijgm_s331378 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8742603 proquest_miscellaneous_2619215582 proquest_journals_2620001752 gale_infotracmisc_A694067386 gale_infotracacademiconefile_A694067386 gale_healthsolutions_A694067386 pubmed_primary_35018112 crossref_primary_10_2147_IJGM_S331378 crossref_citationtrail_10_2147_IJGM_S331378 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-01-01 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | New Zealand |
| PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
| PublicationTitle | International journal of general medicine |
| PublicationTitleAlternate | Int J Gen Med |
| PublicationYear | 2022 |
| Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Dove Medical Press |
| Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove – name: Dove Medical Press |
| References | Yao (ref18) 2021; 21 Si (ref15) 2016; 7 Lu (ref5) 2018; 16 Yoshihara (ref9) 2013; 4 Yuan (ref25) 2021; 11 Xiong (ref22) 2019; 234 Janakiram (ref23) 2015; 21 Van Calster (ref14) 2018; 74 Chen (ref21) 2020; 24 Gamage (ref3) 2021; 120 Kopp (ref16) 2018; 172 Cai (ref4) 2021; 21 Yan (ref17) 2017; 46 Sepulveda (ref13) 2020; 22 Zou (ref6) 2018; 97 Lin (ref24) 2016; 62 Shi (ref10) 2020; 10 Li (ref20) 2021; 28 Li (ref12) 2017; 77 Ahmed (ref19) 2020; 14 Dekker (ref1) 2019; 394 Ye (ref11) 2019; 10 Zhou (ref7) 2020; 2020 Smith (ref2) 2018; 18 Chen (ref8) 2018; 1711 |
| References_xml | – volume: 21 start-page: 340 year: 2021 ident: ref18 publication-title: Cancer Cell Int doi: 10.1186/s12935-021-02027-2 – volume: 16 start-page: 4879 year: 2018 ident: ref5 publication-title: Exp Ther Med doi: 10.3892/etm.2018.6775 – volume: 10 start-page: 2368 year: 2019 ident: ref11 publication-title: Front Immunol doi: 10.3389/fimmu.2019.02368 – volume: 21 start-page: 2359 year: 2015 ident: ref23 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-1495 – volume: 62 start-page: 335 year: 2016 ident: ref24 publication-title: Mol Cell doi: 10.1016/j.molcel.2016.03.021 – volume: 97 start-page: 369 year: 2018 ident: ref6 publication-title: Eur J Cell Biol doi: 10.1016/j.ejcb.2018.04.005 – volume: 2020 start-page: baaa021 year: 2020 ident: ref7 publication-title: Database doi: 10.1093/database/baaa021 – volume: 172 start-page: 393 year: 2018 ident: ref16 publication-title: Cell doi: 10.1016/j.cell.2018.01.011 – volume: 46 start-page: 170 year: 2017 ident: ref17 publication-title: Curr Opin Genet Dev doi: 10.1016/j.gde.2017.07.009 – volume: 28 start-page: 1046 year: 2021 ident: ref20 publication-title: Cancer Gene Ther doi: 10.1038/s41417-020-00267-4 – volume: 394 start-page: 1467 year: 2019 ident: ref1 publication-title: Lancet doi: 10.1016/S0140-6736(19)32319-0 – volume: 1711 start-page: 243 year: 2018 ident: ref8 publication-title: Methods Mol Biol doi: 10.1007/978-1-4939-7493-1_12 – volume: 18 start-page: 611 year: 2018 ident: ref2 publication-title: Expert Rev Anticancer Ther doi: 10.1080/14737140.2018.1480942 – volume: 24 start-page: 3648 year: 2020 ident: ref21 publication-title: Eur Rev Med Pharmacol Sci doi: 10.26355/eurrev_202004_20827 – volume: 21 start-page: 569 year: 2021 ident: ref4 publication-title: Bosn J Basic Med Sci doi: 10.17305/bjbms.2020.5617 – volume: 10 start-page: 846 year: 2020 ident: ref10 publication-title: Front Oncol doi: 10.3389/fonc.2020.00846 – volume: 120 start-page: 104642 year: 2021 ident: ref3 publication-title: Exp Mol Pathol doi: 10.1016/j.yexmp.2021.104642 – volume: 11 start-page: 614778 year: 2021 ident: ref25 publication-title: Front Oncol doi: 10.3389/fonc.2021.614778 – volume: 4 start-page: 2612 year: 2013 ident: ref9 publication-title: Nat Commun doi: 10.1038/ncomms3612 – volume: 234 start-page: 14031 year: 2019 ident: ref22 publication-title: J Cell Physiol doi: 10.1002/jcp.28090 – volume: 77 start-page: e108 year: 2017 ident: ref12 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-0307 – volume: 14 start-page: 2994 year: 2020 ident: ref19 publication-title: Mol Oncol doi: 10.1002/1878-0261.12851 – volume: 74 start-page: 796 year: 2018 ident: ref14 publication-title: Eur Urol doi: 10.1016/j.eururo.2018.08.038 – volume: 7 start-page: 81452 year: 2016 ident: ref15 publication-title: Oncotarget doi: 10.18632/oncotarget.13263 – volume: 22 start-page: 3 year: 2020 ident: ref13 publication-title: J Mol Diagn doi: 10.1016/j.jmoldx.2019.08.006 |
| SSID | ssj0066613 |
| Score | 2.4168584 |
| Snippet | Currently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a vital role in... Background: Currently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a... Na Li,1 Jiangli Shen,1 Ximin Qiao,2 Yuan Gao,3 Hong-Bo Su,4 Shuai Zhang5 1Department of Anorectal Surgery, Xianyang Central Hospital, Xianyang, Shaanxi... |
| SourceID | doaj unpaywall pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 33 |
| SubjectTerms | Analysis Cancer Cancer therapies Chemotherapy Colorectal cancer Development and progression Ferroptosis Gastrointestinal diseases Gene expression Genetic aspects Genomes Genomics immune infiltration lncrnas Medical prognosis Metabolism Metastasis Mortality Nomograms Normal distribution Optimization algorithms Original Research Patients Prognosis Radiation therapy RNA Software Survival analysis T cells tcga Tumors |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dj5QwEG_MPagv5vxGT8XEjweDAm0pPK4b1_PibYznJffWlLasmD3YABvjf-8MZcnixfjiEwkdPjoznQ-Y_oaQF7E1WZEnSVCAewgYjXmQxzoPTCaKjOVMpLavtlgmx-fs5IJf7LX6wpowBw_sGAcJuy5EwpRA1BaBaHUpTYo0zq1iOoosWt8wzXbJlLPBEJP3jZGjCHIkARe6knfsyfPu08nH07dnlEYUW6vtOaMes_-qZd5zTX-WTd7YVhv166dar_d80uKQ3BqCSX_mJnGbXLPVHXL9dPhdfpeoz3W18pd1Fcxr9FH-1-XMPytXDs2z9XeyscbH77H-wjZNvenqtmz9Lw3epoNjjbV4cKas_DmYSjSR8NA5qktzj5wvPnybHwdDT4VAQ2bRBZm1nNNYKK6oinTGrM6UCA2PuYFICOK3uAhNWkRhnoUF8B3cv40sMwZCS6MEvU8OqrqyD4kfZdYIrQXTkGbFlKqEhQZUQkEMphMaeuTNjrlSD4Dj2PdiLSHxQFFIFIUcROGRlyP1xgFt_IXuPcpppEF47P4EKI0clEb-S2k88gylLN1e03GRy1mSsbDvg-qR1z0FLnN4aa2G3QowdQTMmlAeTShheerp8E6T5GAeWoldADA-4LFHno_DeCWWvFW23iINQtVxngLNA6d446QdDGMEI2KikhOuTEeq8nsPHp4K7ElAPfJqVN4r_C5_rC5l6_j96H_w-zG5GeO2kf7T1RE56JqtfQLBXJc_7dftb1czQrI priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZGJwEviDuBAUHi8oDCEjuOkweEumplTKyaNibtzXJspxSVpKSpEP-ec3KjYYKnSPFJ4vhcbR9_h5CX1JokS6PIy8A9eCGj3EupTj2TiCwJ01DEts62mEVHF-HxJb_cIbPuLAymVXY2sTbUptC4Rr6PwOloUjn9sPrhYdUo3F3tSmiotrSCeV9DjF0juxSRsUZk9-BwdnrW2WaI1QPWpL9jfZ79T8cfT96dMxYwLLO25Zhq_P6rVnrLTf2dQnljk6_Ur59qudzyT9Pb5FYbWLrjRhLukB2b3yXXT9qt83tEfS7yuTsrcm9SoL9yz2Zj93wxb5A9127HJ2tcXJt1p7Ysi1VVrBdr97TE11RwLTAvD-4scncCZhPNJXx0gqJT3icX08MvkyOvra_gaZhlVF5iLeeMCsUVU4FOQqsTJXzDKTcQFUEsRzPfxFngp4mfRaGCUMAGNjQGwkyjBHtARnmR20fEDRJrhNYi1DDlooypKPQNiIeCeExHzHfI225wpW7Bx7EGxlLCJARZIZEVsmWFQ1711KsGdOMfdAfIp54GobLrG0U5l63mSY7AS9B5gbA_AuEOYxZlMU2tCnUQWIc8Ry7L5txpr_ByHCWhX9dEdcibmgJVHjqtVXtyAX4dwbMGlHsDSlBVPWzuJEm2pmIt_wi2Q170zfgkpr_lttggDcLWcR4DzcNG8PqfbiAZA2gRA5EcjMqwJV98rYHEY4H1CZhDXvfCe2W8F9_m3-W6Ge_H_-__E3KT4uGQeoFqj4yqcmOfQshWpc9aPfwN8dA_lA priority: 102 providerName: ProQuest – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dj5NAEN9ceon64rcneiomfjwYKrAsC4-1sZ4Xr7l4NjmfyLK7VLRCA1Sjf70zLCXlLib6BGEHyjKfu535DSHPfK3iLA1DJwP34ATUZ07qy9RRMc_iIA14pNtsi3l4tAiOz9n5HvG3tTCYVqnKHyYL1Owm6QYhilqwCDwBA8Y5xXLe_ZBB_D0i-4v56eSz6aISORycoslwxxY8r_Ovy-_jmlKPYie1Hd_TQvRfNsQ7nuhiluTVTbEWv36K1WrHBc1umLLAukUuxMyTb-NNk47l7wu4jv83u5vkeheR2hMjQrfIni5ukysn3X_ud4j4UBZLe14WzrRER2d_nE_ss3xpIEFre8tgrWzc1LVnuqrKdVPWeW2fVviYBo4lJvTBlbywp2Bv0c7Cj05R5qq7ZDF7-2l65HSNGRwJy5PGibVmjPpcMEGFJ-NAy1hwVzGfKQinIAj0M1dFmeemsZuFgYAYQns6UAriUyU4vUdGRVno-8T2Yq24lDyQsFbzKRVh4CqQKwGBnAypa5FXW5YlskMtx-YZqwRWL8jg5P3xu5PkzDDYIs976rVB6_gL3Rvkfk-DGNvthbJaJp3KJgwRm-DlOeIFccRJjGiYRX6qRSA9T1vkCcpOYgpWe0uRTMI4cNtmqhZ52VKgrYCXlqIreYCpI68HlIcDStBxORzeymfS2Zg6wVYCGGQw3yJP-2G8E_PmCl1ukAbx7hiLgObAiHM_aYPl6MEIHwj64KsMR4r8S4tAHnFsbEAt8qJXiUvfGxUv6RTvwb8SPiTXfKwvafe4DsmoqTb6EUR9Tfq4U_M_oTtYHg priority: 102 providerName: Unpaywall |
| Title | Long Non-Coding RNA Signatures Associated with Ferroptosis Predict Prognosis in Colorectal Cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35018112 https://www.proquest.com/docview/2620001752 https://www.proquest.com/docview/2619215582 https://pubmed.ncbi.nlm.nih.gov/PMC8742603 https://www.dovepress.com/getfile.php?fileID=77311 https://doaj.org/article/57cf764a7807472398836f82bea4c11e |
| UnpaywallVersion | publishedVersion |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1178-7074 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066613 issn: 1178-7074 databaseCode: KQ8 dateStart: 20080101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ: Directory of Open Access Journals customDbUrl: eissn: 1178-7074 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066613 issn: 1178-7074 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1178-7074 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066613 issn: 1178-7074 databaseCode: DIK dateStart: 20080101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1178-7074 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066613 issn: 1178-7074 databaseCode: GX1 dateStart: 20080101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1178-7074 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066613 issn: 1178-7074 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1178-7074 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066613 issn: 1178-7074 databaseCode: RPM dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1178-7074 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066613 issn: 1178-7074 databaseCode: 7X7 dateStart: 20080101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Databases customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1178-7074 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066613 issn: 1178-7074 databaseCode: BENPR dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Open Access Journals customDbUrl: eissn: 1178-7074 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0066613 issn: 1178-7074 databaseCode: M48 dateStart: 20091101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAWR databaseName: Taylor & Francis eJournals Open Access customDbUrl: eissn: 1178-7074 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066613 issn: 1178-7074 databaseCode: 0YH dateStart: 20081201 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELf2IcFeEN8ERgkSHw8oI46dOHlAqKvWjYlW1Ual8mQ5jtMVlaSkrWD_PXdJGi0UxEsq5S5pcnf23Tnn3xHyyjNJlMZB4KTgHhzOPN-JPR07SSTSiMdchKasthgGZ2N-PvEnO2TTbbQW4PKvqR32kxoX86NfP64_woD_gGXMlIv3n85PB0eXjFEmwl2yDz4qwiYOA958T4AYvWyUTCnkTAK8ZlUCv3V1yzmVGP7bM_UNV_VnGeXtdbZQ1z_VfH7DR_Xvkjt1cGl3K2u4R3ZMdp_cGtSfzx8Q9TnPpvYwz5xejj7Lvhh27cvZtEL3XNobXZnExvVZu2-KIl-s8uVsaY8KvM0KfnOszYMzs8zuwdSJUyb8aQ_Np3hIxv2TL70zp-6x4GjINFZOZIzvM08oXzFFdcSNjpRwE9_zE4iMIJ7zUjcJU-rGkZsGXEE4YKjhSQKhZqIEe0T2sjwzT4hNI5MIrQXXkHZ5jKmAuwmYiIKYTAfMtci7jXClrgHIsQ_GXEIigqqQqApZq8IirxvuRQW88Q--Y9RTw4Nw2eWJvJjKevRJH8GX4OEFQv8IhDwMWZCGXmwU15Qai7xALctq72kz6GU3iLhb9kW1yNuSAw0RHlqrevcCvDoCaLU4D1ucMFx1m7yxJLmxdoldATBe8D2LvGzIeCWWwGUmXyMPQtf5fgg8jyvDa166gmWkQBEtk2xJpU3JZlclmHgosEcBs8ibxni35D37Nv0ul5W8n_5XVM_IgYd7RMp1qkOytyrW5jlEbqu4Q3bFRHTI_vHJcHTRKdc_4Hg6oZ1yuAJlPBx1v_4G6qhEiQ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVqJcEG8MhRqJwgGZ2t61HR8qlIaWpE2iqg-pt2W9uw5BwQ52oqp_jt_GjF_EVHDrKZJ37Kx3ZuexnvmGkLeuVmEc-b4Vg3mwGHU9K3JlZKkwiEMWsaCji2yLsd-_YEeX3uUa-VXXwmBaZa0TC0WtUoln5LsInI4q1XM_zX9a2DUKv67WLTRE1VpB7RUQY1Vhx7G-voIQLt8bfAZ-77ju4cF5r29VXQYsCb72wgq19jzqBsITVDgyZFqGIrCV53oKfAPwaNzYVp3YsaPQjn0mwCBqRzOlwNlSIqDw3Dtkg1EWQvC3sX8wPjmtbQHEBg4t0-2xH9Du4OjL6OMZpQ7Ftm4rhrDoF3DTKqyYxb9TNjeXyVxcX4nZbMUeHj4g9ytH1uyWkveQrOnkEbk7qj7VPyZimCYTc5wmVi9F-2iejrvm2XRSIonmZi0XWpl4Fmwe6ixL54s0n-bmSYaPWcBvinmAcGWamD1Q06ie4U97KKrZE3JxKyv9lKwnaaKfE9MJtQqkDJiEEM-lVPjMViCOAvw_6VPbIB_qxeWyAjvHnhszDkEPsoIjK3jFCoPsNNTzEuTjH3T7yKeGBqG5iwtpNuHVTuceAj3B5AOEGQoQXrFD_bjjRlow6TjaINvIZV7WuTYKhnf9kNlFD1aDvC8oUMXApKWoKiXg1RGsq0W51aIE1SDbw7Uk8Uo15fzPRjLIm2YY78R0u0SnS6RBmDzP6wDNs1LwmpcuISAdGAlaItlalfZIMv1WAJd3AuyHQA3yrhHeG-s9_T75wfNyvV_8f_7bZLN_Phry4WB8_JLcc7EwpTgc2yLri2ypX4G7uIheV3vSJF9vWw38BtUxe9g |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIhUuiDeGQo1E4YBM7F3bax8QCimh6SOqaCvlZta76xAU7GAnqvrX-HXM-EVMBbeeInnHznpmdh7r2W8IeUW1CpPY960E3IPlMupZMZWxpUKehG7s8kCX1RZjf__cPZh4kw3yqzkLg2WVjU0sDbXKJO6R9xA4HU2qR3tJXRZxsjf8sPhpYQcp_NLatNOoVORQX15A-la8H-2BrHcpHX46G-xbdYcBS0KcvbRCrT2PUS48wYQjQ1fLUHBbedRTEBdANEMTWwWJY8ehnfiuAGeoHe0qBYGWEpzBc2-Qm5yxEMsJ-aRN9iArcFhVaI-dgHqjg8_H704Zcxg2dFtzgWWngKv-YM0h_l2seWuVLsTlhZjP1zzh8C65U4ewZr_SuXtkQ6f3ydZx_ZH-ARFHWTo1x1lqDTL0jOaXcd88nU0rDNHCbDRCKxN3gc2hzvNsscyKWWGe5PiYJfxmWAEIV2apOQADjYYZ_nSASpo_JOfXwudHZDPNUv2EmE6oFZeSuxKSO8qY8F1bgSIKiPykz2yDvG2YG8ka5hy7bcwjSHdQFBGKIqpFYZDdlnpRwXv8g-4jyqmlQVDu8kKWT6N6jUceQjzB5DkCDHEEVgyYnwQ01sKVjqMNsoNSjqoTrq1pifp-6Npl91WDvCkp0LjApKWoz0jAqyNMV4dyu0MJRkF2hxtNimqjVER_lpBBXrbDeCcW2qU6WyENAuR5XgA0jyvFa1-6An90YIR3VLLDle5IOvtWQpYHHDshMIO8bpX3Cr9n36c_oqLi99P_z3-HbMHij45G48Nn5DbFEynlrtg22VzmK_0c4sRl_KJckCb5et0W4Ddpmnly |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dj5NAEN9ceon64rcneiomfjwYKrAsC4-1sZ4Xr7l4NjmfyLK7VLRCA1Sjf70zLCXlLib6BGEHyjKfu535DSHPfK3iLA1DJwP34ATUZ07qy9RRMc_iIA14pNtsi3l4tAiOz9n5HvG3tTCYVqnKHyYL1Owm6QYhilqwCDwBA8Y5xXLe_ZBB_D0i-4v56eSz6aISORycoslwxxY8r_Ovy-_jmlKPYie1Hd_TQvRfNsQ7nuhiluTVTbEWv36K1WrHBc1umLLAukUuxMyTb-NNk47l7wu4jv83u5vkeheR2hMjQrfIni5ukysn3X_ud4j4UBZLe14WzrRER2d_nE_ss3xpIEFre8tgrWzc1LVnuqrKdVPWeW2fVviYBo4lJvTBlbywp2Bv0c7Cj05R5qq7ZDF7-2l65HSNGRwJy5PGibVmjPpcMEGFJ-NAy1hwVzGfKQinIAj0M1dFmeemsZuFgYAYQns6UAriUyU4vUdGRVno-8T2Yq24lDyQsFbzKRVh4CqQKwGBnAypa5FXW5YlskMtx-YZqwRWL8jg5P3xu5PkzDDYIs976rVB6_gL3Rvkfk-DGNvthbJaJp3KJgwRm-DlOeIFccRJjGiYRX6qRSA9T1vkCcpOYgpWe0uRTMI4cNtmqhZ52VKgrYCXlqIreYCpI68HlIcDStBxORzeymfS2Zg6wVYCGGQw3yJP-2G8E_PmCl1ukAbx7hiLgObAiHM_aYPl6MEIHwj64KsMR4r8S4tAHnFsbEAt8qJXiUvfGxUv6RTvwb8SPiTXfKwvafe4DsmoqTb6EUR9Tfq4U_M_oTtYHg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long+Non-Coding+RNA+Signatures+Associated+with+Ferroptosis+Predict+Prognosis+in+Colorectal+Cancer&rft.jtitle=International+journal+of+general+medicine&rft.au=Su%2C+Hong-Bo&rft.au=Li%2C+Na&rft.au=Zhang%2C+Shuai&rft.au=Gao%2C+Yuan&rft.date=2022-01-01&rft.pub=Dove+Medical+Press+Limited&rft.issn=1178-7074&rft.eissn=1178-7074&rft.volume=15&rft.spage=33&rft_id=info:doi/10.2147%2FIJGM.S331378&rft.externalDBID=n%2Fa&rft.externalDocID=A694067386 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-7074&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-7074&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-7074&client=summon |